does blue cross blue shield cover glp 1 medications Ozempic? Why we are changing coverage

PlexusDx genetic insights may help provide context for broader metabolic health conversations with qualified providers

Cardiovascular Outcomes with Orally Administered Semaglutide PIONEER 6 (NCT02692716) was an event-driven CVOT designed to confirm that treatment with orally administered semaglutide does not result in an unacceptable increase in CV risk compared with placebo

Protect your hair by wearing hats or using hair products with UV filters when spending extended periods in the sun

The specific additives in your compounded formulation, whether methylcobalamin B12 or cyanocobalamin, glycine or another stabilizer, can affect tolerability and should be discussed with your prescriber